About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...

This scan can also be used to diagnose: The amount of functioning kidney disease. Blood flow to the kidneys. Possible narrowing of the renal arteries. Rejection of a transplanted kidney. Your provider ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

The donation from philanthropists Lorraine and Bill Dodero will establish a center named in the couple’s honor that UH says ...

The most common symptoms I hear from my patients are leg cramping or discomfort with walking. They often tell me they can ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

For 6 years, a college cross-country skier experiened pain that kept her from school and skiing. Finally, she was diagnosed ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Adults with type 1 diabetes who partake in weight cycling and repeatedly lose and regain body weight are more likely to develop diabetic kidney disease, researchers reported in The Journal of Clinical ...